Global Stem Cell Umbilical Cord Blood Market, By Storage Service (Public Cord Blood Banks, Private Cord Blood Banks, and Hybrid Cord Blood Banks), Therapeutics (Cancer, Diabetes, Blood Diseases, Immune Disorders, Metabolic Disorders, and Other Diseases), Application (Transplant Medicine and Regenerative Medicine), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Stem Cell Umbilical Cord Blood Market
Data Bridge Market Research analyses that the stem cell umbilical cord blood market will exhibit a CAGR of around 12.04% for the forecast period of 2021-2028. Rising awareness about stem cell umbilical cord blood biotechnology, rising prevalence of cancer and increasing public and private expenditure for the development of healthcare infrastructure especially in emerging economies are the major factors attributable to the growth of stem cell umbilical cord blood market. This signifies that the stem cell umbilical cord blood market value, which was USD 3,934.77 million in 2020, will rocket up to USD 9,770.23 million by the year 2028.
Stem cell therapy is gaining proficiency in the healthcare sector. Stem cell therapy is used to prevent a disease or any condition by using stem cells. The therapy promotes the repair response of injured of dysfunctional cells. Here arises the need for cord blood. Cord blood is one of the rich sources of stem cells. Cord blood contains blood forming stem cells that is used to treat patients suffering from conditions like blood cancer, leukaemia and so on.
Upsurge in the in the child birth rate globally is one of the major factors inducing growth in the demand for stem cell umbilical cord blood biotechnological procedure. Rising prevalence of chronic diseases such as cancer, diabetes, blood diseases, and other immunity related diseases will further generate lucrative and remunerative growth opportunities for the stem cell umbilical cord blood market. Growing awareness among consumers coupled with rising genetic testing will also act as important market growth determinants. Rising emergence of suitable payment plans, increasing number of hospitals and increasing personal disposable income will also propel growth in the market value.
However, high costs associated with stem cell therapy will derail the stem cell umbilical cord blood market growth rate. Also, several legal and ethical issues during collection will hamper the market growth rate. Unavailability of donors will also create hindrances.
This stem cell umbilical cord blood market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on stem cell umbilical cord blood market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Stem Cell Umbilical Cord Blood Market Scope and Market Size
The stem cell umbilical cord blood market is segmented on the basis of storage service, therapeutics and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- By storage service, the global stem cell umbilical cord blood market is segmented into public cord blood banks, private cord blood banks, and hybrid cord blood banks.
- On the basis of therapeutics, the stem cell umbilical cord blood market is segmented into cancer, diabetes, blood diseases, immune disorders, metabolic disorders, and other diseases.
- On the basis of application, the stem cell umbilical cord blood market is segmented into transplant medicine and regenerative medicine.
Stem Cell Umbilical Cord Blood Market Country Level Analysis
The stem cell umbilical cord blood market is analysed and market size insights and trends are provided by storage service, therapeutics and application as referenced above.
The countries covered in the stem cell umbilical cord blood market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the stem cell umbilical cord blood market owing to the rising expenditure for research and development activities on genetic testing coupled with favourable reimbursement scenario in the region. Asia-Pacific on the other hand is projected to undergo the highest growth rate during the forecast period owing to the rising prevalence of cancer and other chronic diseases and improving healthcare infrastructure.
The country section of the stem cell umbilical cord blood market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The stem cell umbilical cord blood market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the stem cell umbilical cord blood market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Stem Cell Umbilical Cord Blood Market Share Analysis
The stem cell umbilical cord blood market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to stem cell umbilical cord blood market.
The major players covered in the stem cell umbilical cord blood market report are CORDLIFE GROUP LIMITED, CBR Systems, Inc., Cryo-Cell, MEDIPOST, Americord Registry LLC., ESPERITE NV, LifeCell International Pvt. Ltd., Global Cord Blood Corporation., ViaCord., Vita 34 1997 - 2021, Inc., AMAG Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., Cytori Therapeutics Inc., Athersys, Inc., Cord for Life, National Cord Blood Program and Precision Cellular Storage among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available: Global Stem Cell Umbilical Cord Blood Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.